GSE233679 nicotinamide 14 v 10 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE233679_nicotinamide_14_v_10_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE233679_nicotinamide_14_v_10_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE233679_nicotinamide_14_v_10_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE233679_nicotinamide_14_v_10_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

transmembrane protein 198B (pseudogene)

Gene

ETS repressor factor like

Gene

long intergenic non-protein coding RNA 1013

Gene

PZP alpha-2-macroglobulin like 2, pseudogene

Gene

CTNNA1 antisense RNA 1

Gene

OPCML intronic transcript 1

Gene

PEBP4 antisense RNA 1

Gene

uncharacterized LOC124904695

Gene

long intergenic non-protein coding RNA 1892

Gene

BMS1 pseudogene 3

  • Gene

    transmembrane protein 198B (pseudogene)


  • Gene

    ETS repressor factor like


  • Gene

    long intergenic non-protein coding RNA 1013


  • Gene

    PZP alpha-2-macroglobulin like 2, pseudogene


  • Gene

    CTNNA1 antisense RNA 1


  • Gene

    OPCML intronic transcript 1


  • Gene

    PEBP4 antisense RNA 1


  • Gene

    uncharacterized LOC124904695


  • Gene

    long intergenic non-protein coding RNA 1892


  • Gene

    BMS1 pseudogene 3

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.